Skills in Demand visa subclass 482
A temporary employer-sponsored pathway that may be available through an approved DAMA employer and applicable labour agreement arrangements.
Learn moreRetail Pharmacist – ANZSCO 251513
DAMA OCCUPATION OVERVIEW
Retail Pharmacist
ANZSCO 251513
Retail Pharmacist (ANZSCO 251513) is available under selected DAMA arrangements. Participating regions, occupation conditions, concessions and employer-sponsored visa pathways may vary between DAMAs. Review the current regions and requirements below.
Occupation guide
Occupation details and duties
Retail Pharmacist dispenses prescribed pharmaceuticals to the public, educates customers on health promotion, disease prevention and the proper use of medicines, and sells non-prescription medicines and related goods in a community pharmacy. Registration or licensing is required.
Typical tasks and duties
Retail Pharmacist may perform the following tasks:
- receiving prescriptions, checking patients' medicine histories, and ensuring optimal dosage and methods of administration and drug compatibility before dispensing
- preparing or supervising the preparation and labelling of liquid medicines, ointments, powders, tablets and other medications to fill prescriptions
- advising prescribers on drug incompatibility and contra-indications
- reviewing and monitoring the medicine therapy of individual patients, and assessing the effectiveness of the total medicine therapy
- maintaining prescription files and recording issue of narcotics, poisons and habit-forming drugs
- storing and preserving vaccines, serums and other drugs subject to deterioration
- supplying non-prescription medicines, and diagnostic and therapeutic aids
- supervising and coordinating the work of Pharmacy Technicians, pharmacy interns and Pharmacy Sales Assistants
- conducting research to develop and improve pharmaceuticals, cosmetics and related chemical products
- conferring with Chemists, Engineering Professionals and other professionals about manufacturing techniques and ingredients
- testing and analysing drugs to determine their identity, purity and strength in relation to specified standards
- developing standards for drugs used in pharmaceuticals
Employer-sponsored pathways
Possible DAMA pathways
Availability depends on the relevant DAMA agreement, occupation conditions, concessions, employer endorsement, nomination requirements and the applicant’s circumstances.
Employer Nomination Scheme subclass 186
A permanent employer-sponsored pathway that may be available where the relevant DAMA agreement and nomination requirements permit it.
Learn moreSkilled Employer Sponsored Regional visa subclass 494
A provisional regional employer-sponsored pathway that may be available through an endorsed employer in a participating DAMA region.
Learn moreDAMA availability
Occupation available in 4 DAMA regions
Retail Pharmacist is recorded as available in the DAMA regions listed below. Open a region card to review the relevant regional DAMA information.
Important notes
- Inclusion on a DAMA occupation list does not guarantee employer sponsorship, endorsement, nomination or visa eligibility.
- Occupation conditions, concessions and visa pathways vary between DAMAs and may change over time.
Check your options
Check your DAMA and employer-sponsored options
We can review the relevant DAMA agreement, occupation conditions, employer sponsorship and visa requirements.
PointsView report available
Retail Pharmacist historical SkillSelect report
The current PointsView report includes historical SkillSelect data through June 2026 for ANZSCO 251513.
View report details
Purchase full report
Historical information does not predict invitations, visa outcomes or migration eligibility.
Reviewed by Principal Migration Consultant
Reviewed by Mohammad Reza Azimi
This occupation page has been reviewed for migration context by Shada Migration Services. Mohammad has assisted clients with Australian migration matters since 2009 and holds a Graduate Certificate in Migration Law from the Australian National University.
Last reviewed: July 2026
